HBC Financial Services’s Moderna MRNA Stock Holding History

HBC Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$0	Hold	5	–	–	﹤0.01%	191
2024 Q3	$0	Sell	5 -10	-67%	-$918	﹤0.01%	185
2024 Q2	$1K	Hold	15	–	–	﹤0.01%	152
2024 Q1	$1K	Hold	15	–	–	﹤0.01%	153
2023 Q4	$1K	Hold	15	–	–	﹤0.01%	154
2023 Q3	$1K	Hold	15	–	–	﹤0.01%	162
2023 Q2	$1K	Hold	15	–	–	﹤0.01%	155
2023 Q1	$2K	Hold	15	–	–	﹤0.01%	159
2022 Q4	$2K	Hold	15	–	–	﹤0.01%	144
2022 Q3	$1K	Hold	15	–	–	﹤0.01%	154
2022 Q2	$2K	Hold	15	–	–	﹤0.01%	155
2022 Q1	$2K	Hold	15	–	–	﹤0.01%	148
2021 Q4	$3K	Hold	15	–	–	﹤0.01%	146
2021 Q3	$4K	Buy	+15	New	+$5.53K	﹤0.01%	126

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

HBC Financial Services's MRNA Position: Q4 2024 in Review

HBC Financial Services held its Moderna (MRNA) position steady in Q4 2024 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #191.

HBC Financial Services first reported a position in MRNA in Q3 2021 and has held it in 14 quarters since. The position peaked at $4K in Q3 2021. 747 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

HBC Financial Services held 5 shares of Moderna worth $0 as of Q4 2024.
HBC Financial Services left its Moderna share count unchanged in Q4 2024.
Moderna made up ﹤0.01% of HBC Financial Services's portfolio in Q4 2024, its #191 holding.
HBC Financial Services first reported a position in Moderna in Q3 2021 and has held it in 14 quarters since.
HBC Financial Services's Moderna position peaked at $4K in Q3 2021.
747 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.